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Design of functionalized b-ketoenole derivatives
as eﬃcient fluorescent dyes for detection of
amyloid fibrils†
Vladyslava Kovalska, *a Svitlana Chernii,ab Mykhaylo Losytskyy,bc
Iryna Tretyakova,b Yan Dovbii,b Alexandr Gorski,d Victor Chernii,b
Rafal Czerwieniec*e and Sergiy Yarmoluka
The self-association of proteins into insoluble filamentous aggregates – amyloid fibrils – is associated
with a range of protein deposition disorders. With the aim of developing fluorescent probes sensitive to
amyloid aggregates, a new series of derivatives of (2Z,5Z,7E)-6-hydroxy-2-(alkylamino)-8-arylocta-2,5,7-
trien-4-one dyes was synthesized. These dyes are less sensitive to native amyloidogenic proteins, such
as insulin or lysozyme, while they have the ability to exhibit a pronounced fluorescence response in the
presence of amyloid fibrils of these proteins depending on the structure of the dye tail groups. The dyes
associated with the fibrils show green-yellow emission (495–540 nm) and rather large Stokes shift values
(68–125 nm). Upon binding to the fibrils, the fluorescence quantum yields of the dyes could increase
by a hundred times up to 0.18–0.47, and the fluorescence intensity decay time strongly enhances up to
0.9–1.3 ns. These features make ketoenoles attractive as probes for the detection of amyloid fibrils;
besides, the efficiency of these dyes for real-time monitoring of the kinetics of protein aggregation is
shown. The best sensing properties were shown by dyes 2 and 9 bearing short amino tail groups
(correspondingly 2-methoxyethyl and 2-hydroxyethyl) and a 4-substituted phenyl moiety at the other
end of the ketoenole backbone.
Introduction
Amyloid fibrils are insoluble protein aggregates that can be formed
by diﬀerent proteins and polypeptides but share a common
structure – they consist of b-pleated filaments twisted together.1
Amyloid aggregation is associated with a range of protein deposi-
tion disorders;2 the reduction of the amount of such aggregates is
one of the strategies for developing drugs against neurodegenera-
tive disorders and amyloidoses. Besides their role in pathological
processes, amyloid fibrils fulfill important biological functions
in cells.3,4 For example, curli fibrils5 have adhesive properties
and are involved in the formation of E. coli biofilms. Functional
amyloids are involved in melanin synthesis in mammalian
melanosomes6 and human peptide hormone storage.7 In
addition, amyloid fibrils are widely studied as templates or
building blocks8 in bionanomaterials science as components of
biomembranes,9 biosensors,10 and hydrogels for cell culture
and for drug delivery.11
A range of methods, in particular, circular dichroism spectro-
scopy, X-ray diﬀraction, and atomic force microscopy,12–14 are
used to monitor the self-aggregation of proteins into fibrils.
Besides, amyloid aggregation can be detected by fluorescence-
based methods, using dyes sensitive to beta-pleated motifs.3
These dyes are simple and inexpensive tools for the prompt
detection of fibrils, real-time monitoring of amyloid aggregation
kinetics and they are applied in the search for aggregation
inhibitors. For visualization of intracellular and intercellular
amyloid inclusions (for example, neurofibrillary tangles and
senile plaques), fluorescence microscopy is used.15,16 Several
classes of fluorescent compounds, for instance, naphthalenes,17
oligothiophenes,18 and curcumin derivatives,19 were shown
to provide a response upon interaction with fibrils and thus
could be useful for fibril detection. Previously, we have reported
mono and trimethine cyanine dyes20,21 as highly eﬃcient
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amyloid-sensitive probes, which exhibit a strong fluorescent
response upon binding to fibrils. Besides, styrylpyridinium
dyes22 have also shown the ability to fluorescently sense insulin
amyloid fibrils. The commonly used dye for the detection and
visualization of amyloid aggregates is Thioflavin T, a derivative
of the N-methylated benzothiazolium ion.23 The fluorescence
emission of the Thioflavin T dye is used for monitoring the
fibrillation kinetics and in the study of the prevention of amyloid
formation by anti-amyloidogenic compounds.24 Another widely
known amyloid-sensitive dye, Congo Red, has been used for the
detection and visualization of amyloid fibrils in histological
specimen materials, for example, histological sections showing
apple-green birefringence in polarized light.25
Recently, we have discovered b-ketoenoles as a new class of
dyes possessing fluorescence sensitivity to amyloid fibrils.26
These compounds are able to increase their fluorescence
intensity by dozens of times upon interaction with fibrillar
proteins while demonstrating a relatively weak response in the
presence of native ones. They bind to fibrils with high binding
constant values of about 2  105 M1. Among the advantages of
these compounds, the large Stokes shift values (about 100 nm
or more) should be mentioned. It was shown that variation of
the aminoalkyl substituent in the b-ketoenole molecule could
strongly aﬀect its amyloid sensing abilities.26
Herein, we report a new series of (2Z,5Z,7E)-6-hydroxy-2-
(alkylamino)-8-arylocta-2,5,7-trien-4-one dyes with variations of
tail amino substituents and aryl moieties (Scheme 1) and study
them as fluorescent sensors for amyloid fibrils of proteins. The
spectral-luminescent properties of the compounds as well as
those in the presence of the proteins insulin and lysozyme in
the native and fibrillar form are characterized. The relation
between the chemical nature of the substituents in the dye
molecule and eﬃciency of its sensing properties is analyzed.
The obtained results suggest that the designed ketoenole
derivatives are eﬃcient tools for the detection of amyloid fibrils
and the study of protein aggregation.
Materials and methods
1. Synthesis and characterization of the dyes
General procedure. (E)-4-Hydroxy-6-methyl-3-(3-arylacryloyl)-
2H-pyran-2-one (5 mmol) was added to 5 ml of dimethylforma-
mide (DMF) and the mixture was heated to 130 1C. A small
excess amount (5.5 mmol) of the respective aliphatic amine was
added to this solution and left for 3–5 min until the release of
carbon dioxide ceased. A change in the color of the reaction
mixture from yellow to red was observed. After cooling, the
reaction mixture was precipitated with water (15 ml). The
resulting solid was filtered, washed with water (3  10 ml) and
crystallized from EtOH or a DMF–EtOH mixture (7 : 3 vol : vol).
The crystals were collected by vacuum filtration and washed
with EtOH (2  10 ml) and water (2  10 ml), and dried. The
crystals of compounds 3 and 5 obtained in this way were
suitable for X-ray studies (Scheme 2).
Molecular structures were confirmed by means of 1H NMR
spectroscopy, elemental analysis, and (for compounds 3 and 5)
X-ray diﬀractometry.
1. (2E,5Z,7E)-2-(Dodecylamino)-6-hydroxy-8-(4-propoxyphenyl)-
octa-2,5,7-trien-4-one. Yield: 55%. M.p.: 87–90 1C. IR cm1. (cryst.
powd.): 3374(br), 2955(w), 2911(w), 2847(w), 1635(w), 1612(w),
1573(s), 1545(m), 1504(w), 1465(w), 1413(w), 1305(m), 1284(w),
1245(m), 1194(w), 1176(w), 1147(w), 1106(w), 1075(w), 1046(w),
1021(w), 974(w), 966(m), 948(w), 881(w), 824(m), 812(w), 806(w),
796(w), 765(w), 742(w), 721(w), 713(w), 543(w), 516(w), 496(w),
460(w), 421(w). 1H NMR (300 MHz, chloroform-d) d 15.08
(s, 1H), 10.78, 10.28 (t + t, 1H), 7.54, 7.24 (d + d, J = 16.1 Hz,
1H), 7.43, 7.34 (d + d, J = 8.7 Hz, 2H), 6.90–6.72 (m, 2H), 6.66, 6.22
(d + d, J = 15.8 Hz, 1H), 5.15, 4.70 (s + s, 1H), 4.95, 3.53 (s + s, 1H),
3.87 (td, J = 6.5, 4.1 Hz, 2H), 3.17 (dq, J = 10.7, 6.7 Hz, 2H),
2.29–2.05 (m, 2H), 1.90, 1.86 (s + s, 3H), 1.81–1.66 (m, 2H), 1.53
(d, J = 6.7 Hz, 2H), 1.41–1.13 (m, 16H), 0.97 (t, J = 7.4, 1.1 Hz, 3H),
0.81 (t, J = 6.5 Hz, 3H). Found (%): C, 76.50; H, 9.91; N, 3.12. Anal.
calcd (%) for C29H45NO3: C, 76.44; H, 9.95; N, 3.07; O, 10.53.
Scheme 1 Formulas of b-ketoenole dyes.
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2. (2E,5Z,7E)-8-(4-(Dimethylamino)phenyl)-6-hydroxy-2-(2-
methoxyethylamino)octa-2,5,7-trien-4-one. Yield: 64%. M.p.:
118–121 1C. IR cm1 (cryst. powd.): 3359(w), 3195(w), 2923(w),
2851(w), 1635(w), 1605(m), 1558(s), 1418(m), 1366(m), 1303(m),
1230(w), 1186(w), 1146(m), 1122(m), 973(w), 937(w), 856(w),
817(w), 728(w), 650(w), 558(w), 517(w), 495(w), 434(w).
1H NMR (300 MHz, chloroform-d) d 15.20 (s, 1H), 10.89, 10.34
(t + t, J = 5.0 Hz, 1H), 7.45, 7.38 (d + d, J = 8.9 Hz, 2H), 7.59, 7.31
(d + d, J = 15.7 Hz, 1H), 6.67 (d, J = 3.0 Hz, 2H), 6.63, 6.24 (d + d,
J = 15.7 Hz, 1H), 5.21, 4.78 (s + s, 1H), 5.07, 3.59 (s + s, 1H),
3.57–3.41 (m, 4H), 3.40, 3.37 (s + s, 3H), 3.02, 2.99 (s + s, 6H),
1.98, 1.94 (s + s, 3H). Found (%): C, 69.10; H, 7.87; N, 8.42. Anal.
calcd (%) for C19H26N2O3: C, 69.06; H, 7.93; N, 8.48; O, 14.53.
3. (2E,5Z,7E)-6-Hydroxy-2-(2-methoxyethylamino)-8-phenylocta-
2,5,7-trien-4-one. Yield: 45%. M.p.: 99–102 1C. IR cm1 (cryst.
powd.): 3058(w), 2983(w), 2925(w), 2882(w), 2828(w), 1644(w),
1564(s), 1417(m), 1305(m), 1235(w), 1193(w), 1152(w), 1125(m),
1077(w), 1034(w), 969(m), 936(m), 859(w), 806(m), 753(w), 725(w),
692(w), 586(w), 559(w), 546(w), 491(w), 464(w). 1H NMR (400 MHz,
chloroform-d) d 15.06 (s, 1H), 10.89, 10.45 (s + s, 1H), 7.72–7.21
(m, 6H), 6.85, 6.42 (d + d, J = 15.9 Hz, 1H), 5.26, 4.81 (s, 1H),
5.05, 3.62 (s + s, 1H), 3.54 (t, J = 5.1 Hz, 2H), 3.51–3.41 (m, 2H),
3.40, 3.36 (s + s, 3H), 1.99, 1.95 (s + s, 3H). Found (%): C, 71.12;
H, 7.34; N, 4.82. Anal. calcd (%) for C17H21NO3: C, 71.06;
H, 7.37; N, 4.87; O, 16.70.
4. (2E,5Z,7E)-8-(Benzo[d][1,3]dioxol-5-yl)-2-(3-(dimethylamino)-
propylamino)-6-hydroxyocta-2,5,7-trien-4-one. Yield: 45% M.P.:
98–100 1C. IR cm1 (cryst. powd.): 3071(w), 2945(w), 2816(w),
2766(w), 1640(w), 1603(m), 1566(s), 1516(w), 1487(w), 1433(m),
1354(w), 1293(m), 1255(m), 1147(m), 1106(w), 1034(m), 966(w),
939(w), 850(w), 811(w), 725(w), 490(w), 425(w). 1H NMR (400MHz,
chloroform-d) d 15.14 (s, 1H), 10.85, 10.38 (t + t, 1H), 7.55, 7.26
(d + d, J = 15.6 Hz, 1H), 7.12–6.89 (m, 2H), 6.85–6.73 (m, 1H),
6.67, 6.24 (d + d, J = 15.8 Hz, 1H), 6.00, 5.97 (s + s, 2H), 5.22, 4.77
(s + s, 1H), 5.02, 3.58 (s + s, 1H), 3.43–3.19 (m, 2H), 2.56–2.37 (m,
2H), 2.31, 2.27 (s + s, 6H), 1.98, 1.95 (s + s, 3H), 1.90–1.71 (m, 2H).
Found (%): C, 67.05; H, 7.36; N, 7.78. Anal. calcd (%) for
C20H26N2O4: C, 67.02; H, 7.31; N, 7.82; O, 17.85.
5. (2E,5Z,7E)-2-(Benzylamino)-6-hydroxy-8-(4-propoxyphenyl)-
octa-2,5,7-trien-4-one. Yield: 70%. M.p.: 165–168 1C. IR cm1
(cryst. powd.): 3389(br), 2966(w), 2936(w), 2872(w), 1634(w),
1606(m), 1578(s), 1543(s), 1424(w), 1301(m), 1249(m), 1175(w),
1154(w), 1091(w), 1046(w), 1018(w), 972(w), 952(w), 825(w),
804(w), 755(w), 727(w), 703(w), 563(w), 405(m). 1H NMR
(300 MHz, chloroform-d) d 15.12 (s, 1H), 11.15, 10.68 (t, J =
6.1 Hz, 1H), 7.69–7.14 (m, 8H), 6.96–6.82 (m, 2H), 6.73, 6.30
(d + d, J = 15.8 Hz, 1H), 5.26, 4.86 (s + s, 1H), 4.50, 4.46 (d + d,
J = 6.3 Hz, 2H), 4.03–3.87 (m, 2H), 5.12, 3.63, (s + s, 1H),
1.97, 1.94 (s + s, 3H), 1.89–1.71 (m, 2H), 1.04 (t, J = 7.4 Hz, 3H).
Found (%): C, 76.39; H, 7.24; N, 3.67. Anal. calcd (%) for
C24H27NO3: C, 76.36; H, 7.21; N, 3.71; O, 12.72.
6. (2E,5Z,7E)-8-(4-Ethylphenyl)-6-hydroxy-2-(methylamino)octa-
2,5,7-trien-4-one. Yield: 70%. M.p.: 149–151 1C. IR cm1 (cryst.
powd.): 3365(br), 3034(w), 2969(w), 2932(w), 1617(m), 1572(s),
1547(s), 1515(w), 1444(w), 1412(m), 1377(w), 1313(m), 1281(w),
1193(w), 1143(m), 1083(w), 980(w), 969(w), 941(w), 867(w), 828(w),
704(w), 657(w), 449(w). 1H NMR (300 MHz, chloroform-d) d 15.08
(s, 1H), 10.76, 10.27 (t + t, 1H), 7.63, 7.34 (d + d, J = 15.9 Hz, 1H),
7.53–7.13 (m, 4H), 6.81, 6.39 (d + d, J = 15.8 Hz, 1H), 5.25, 4.82
(s + s, 1H), 5.06, 3.61 (s + s, 1H), 2.98, 2.94 (d + d, J = 5.3 Hz, 3H),
2.73–2.57 (m, 2H), 1.98, 1.93 (s + s, 3H), 1.23 (t, J = 7.6 Hz, 3H).
Found (%): C, 75.20; H, 7.77; N, 5.12. Anal. calcd (%) for
C17H21NO2: C, 75.25; H, 7.80; N, 5.16; O, 11.79.
7. (2E,5Z,7E)-8-(Benzo[d][1,3]dioxol-5-yl)-6-hydroxy-2-(methyl-
amino)octa-2,5,7-trien-4-one. Yield: 52%. M.p.: 152–155 1C. IR
cm1 (cryst. powd.): 3200(w), 2899(w), 1607(m), 1574(s), 1547(s),
1488(s), 1447(s), 1407(m), 1316(w), 1289(w), 1257(s), 1193(w),
1139(w), 1103(w), 1075(w), 1034(m), 957(m), 934(m), 798(s),
721(m), 671(w), 594(w), 558(w), 512(w), 490(w), 430(w). 1H NMR
(300 MHz, chloroform-d) d 15.09 (s, 1H), 10.77, 10.23 (t, t, 1H),
7.56, 7.26 (d, d, J = 15.7 Hz, 1H), 7.11–6.90 (m, 2H), 6.86–6.75 (m,
1H), 6.68, 6.25 (d, d, J = 15.7 Hz, 1H), 6.00, 5.97 (s, s, 2H), 5.22,
4.81 (s, s, 1H), 3.59, 5.05 (s, s, 1H), 2.98, 2.94 (d, d, J = 5.3 Hz, 3H),
1.97, 1.93 (s, s, 3H). Found (%): C, 66.93; H, 5.94; N, 4.84. Anal.
calcd (%) for C16H17NO4: C, 66.89; H, 5.96; N, 4.88; O, 22.27.
8. (2E,5Z,7E)-8-(4-(Dimethylamino)phenyl)-2-(3-(dimethyl-
amino)propylamino)-6-hydroxyocta-2,5,7-trien-4-one. Yield: 72%.
M.p.: 117–120 1C. IR cm1 (cryst. powd.): 3042(w), 2943(w),
2860(w), 2815(w), 2766(w), 1637(w), 1607(m), 1565(s), 1516(m),
1417(m), 1357(m), 1307(m), 1286(m), 1227(w), 1186(w), 1144(m),
1102(w), 967(w), 947(w), 814(w), 727(w), 516(w), 495(w), 457(w).
1H NMR (300 MHz, chloroform-d) d 15.27 (s, 1H), 10.85, 10.30
(t + t, J = 5.8 Hz, 1H), 7.59 (d, J = 15.9 Hz, 1H), 7.46, 7.38 (d + d,
J = 8.8 Hz, 2H), 7.59, 7.30 (d + d, J = 15.8 Hz, 1H), 6.73–6.54
(m, 2H), 6.65, 6.23 (d + d, J = 15.7 Hz, 1H), 5.20, 4.75 (s + s, 1H),
5.04, 3.58 (s + s, 1H), 3.41–3.22 (m, 2H), 3.02, 2.99 (s + s, 6H),
2.44–2.29 (m, 2H), 2.24, 2.21 (s + s, 6H), 1.97, 1.93 (s, s, 3H),
1.87–1.63 (m, 2H). Found (%): C, 70.59; H, 8.78; N, 11.72. Anal.
calcd (%) for C21H31N3O2: C, 70.55; H, 8.74; N, 11.75; O, 8.95.
9. (2E,5Z,7E)-6-Hydroxy-2-(2-hydroxyethylamino)-8-(4-propoxy-
phenyl)octa-2,5,7-trien-4-one. Yield: 38%. M.p.: 87–90 1C. IR cm1
(cryst. powd.): 3383(br), 3052(w), 2964(w), 2935(w), 2875(w),
1639(w), 1606(m), 1566(s), 1511(m), 1422(w), 1303(m), 1252(m),
1175(w), 1150(w), 1115(w), 1064(w), 973(w), 934(w), 868(w),
826(w), 808(w), 753(w), 729(w), 698(w), 667(w), 637(w), 518(w),
447(w). 1H NMR (300 MHz, chloroform-d) d 14.96 (s, 1H),
10.86, 10.32 (t + t, 1H), 7.53, 7.25 (d + d, J = 15.8 Hz, 1H),
7.43, 7.34 (d + d, J = 8.7 Hz, 2H), 6.89–6.75 (m, 2H), 6.64, 6.22
Scheme 2 Synthesis of (2Z,5Z,7E)-6-hydroxy-2-(alkylamino)-8-arylocta-2,5,7-trien-4-one compounds.
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(d + d, J = 15.8 Hz, 1H), 5.16, 4.75 (s + s, 1H), 3.95–3.81 (m, 2H),
3.78–3.60 (m, 2H), 5.00, 3.54, (s + s, 1H), 3.47–3.21 (m, 2H), 2.22
(s, 1H), 1.93, 1.90 (s + s, 3H), 1.74 (dt, J = 7.2 Hz, 2H), 0.97
(t, J = 7.4 Hz, 3H). Found (%): C, 68.81; H, 7.57; N, 4.19. Anal.
calcd (%) for C19H25NO4: C, 68.86; H, 7.60; N, 4.23; O, 19.31.
10. (2E,5Z,7E)-6-Hydroxy-2-(2-methoxyethylamino)-8-(thiophen-
2-yl)octa-2,5,7-trien-4-one. Yield: 45%. M.p.: 86–87 1C. IR cm1
(cryst. powd.): 3108(w), 2985(w), 2925(w), 2881(w), 2830(w),
2735(w), 1635(w), 1609(m), 1567(s), 1514(m), 1419(m), 1359(w),
1299(m), 1197(w), 1151(w), 1123(m), 1084(w), 1042(w), 975(w),
954(w), 938(w), 853(w), 823(w), 804(w), 702(w), 659(w), 589(w),
551(w), 488(w), 460(w). 1H NMR (300 MHz, chloroform-d) d 15.07
(s, 1H), 10.89, 10.44 (t + t, 1H), 7.76, 7.46 (d + d, J = 15.5 Hz, 1H),
7.40–6.99 (m, 3H), 6.64, 6.22 (d + d, J = 15.5 Hz, 1H), 5.23, 4.80
(s + s, 1H), 5.04, 3.58 (s + s, 1H), 3.57–3.42 (m, 4H), 3.40, 3.37
(s + s, 3H), 1.99, 1.95 (s + s, 3H). Found (%): C, 61.46; H, 6.57; N,
4.73. Anal. calcd. (%) for C15H19NO3S: C, 61.41; H, 6.53; N, 4.77;
O, 16.36; S, 10.93.
X-ray analysis. 3. (2E,5Z,7E)-6-Hydroxy-2-(2-methoxyethylamino)-
8-phenylocta-2,5,7-trien-4-one. A suitable crystal (0.16  0.15 
0.08 mm) was selected and mounted on a MITIGEN holder
on a SuperNova Atlas diﬀractometer equipped with an Oxford
Cryosystems CryoStream 700 low-temperature apparatus. During
data collection, the crystal was kept at T = 123 K. Data were
collected using CuKa radiation. Cell parameters were retrieved
and refined using CrysAlisPro software (Agilent Technologies UK
Ltd) on 7013 reflections, 42% of the observed reflections. Data
reduction was performed using the CrysAlisPro software (Agilent
Technologies UK Ltd), which corrects for Lorentz polarisation.
The final completeness is 100.00 out to 73.410 in Y. The
absorption coeﬃcient (m) of this material is 0.662 and the
minimum and maximum transmissions are 0.980 and 0.991.
The structure was solved in the space group P212121 (No. 19)
using the OLEX2 computer program27 and refined by least
squares using ShelXL.28 All non-hydrogen atoms were refined
anisotropically. The hydrogen atom positions were calculated
geometrically and refined using the riding model.
Crystal data. C17H21NO3,Mr = 287.35, orthorhombic, P212121
(No. 19), a = 8.0221(2) Å, b = 8.5085(2) Å, c = 23.2424(4) Å,
a = b = g = 901, V = 1586.43(6) Å3, T = 123.00(10) K, Z = 4, Z0 = 1,
m(CuKa) = 0.662, 16 588 reflections measured, 3165 unique
(Rint = 0.0401), which were used in all calculations. The final
wR2 was 0.0784 (all data) and R1 was 0.0316 (I 4 2(I)).
Further crystal and refinement data are provided in Table 1.
5. (2E,5Z,7E)-2-(Benzylamino)-6-hydroxy-8-(4-propoxyphenyl)-
octa-2,5,7-trien-4-one. A suitable crystal (0.20  0.16  0.08 mm)
was selected and mounted on a MITIGEN holder on a SuperNova
Atlas diﬀractometer equipped with an Oxford Cryosystems Cryo-
Stream 700 low-temperature apparatus. During data collection,
the crystal was kept at T = 123 K. Data were collected using
CuKa radiation. Cell parameters were retrieved and refined
using CrysAlisPro (Agilent) on 32 994 reflections, 38% of the
observed reflections. Data reduction was performed using the
CrysAlisPro software (Agilent Technologies UK Ltd), which
corrects for Lorentz polarisation. The final completeness is
100.00 out to 73.556 in Y. The absorption coeﬃcient (m) of this
material is 0.647 at this wavelength (l = 1.54184) and the
minimum and maximum transmissions are 0.989 and 0.995.
The structure was solved in the space group P21/n (No. 14) by
Intrinsic Phasing using the ShelXT structure solution program
and refined by least squares using version 2014/7 of ShelXL. All
non-hydrogen atoms were refined anisotropically. The hydro-
gen atom positions were calculated geometrically and refined
using the riding model.
Crystal data. C48H54N2O6, Mr = 754.93, monoclinic, P21/n
(No. 14), a = 22.0779(2) Å, b = 7.22350(10) Å, c = 25.3699(3) Å,
b = 94.5190(10)1, a = g = 901, V = 4033.41(8) Å3, T = 123.00(10) K,
Z = 4, Z0 = 1, m(CuKa) = 0.647, 86 784 reflections measured, 8076
unique (Rint = 0.0409), which were used in all calculations. The
final wR2 was 0.0961 (all data) and R1 was 0.0345 (I 4 2(I)).
Further crystal and refinement data are provided in Table 1. The
crystallographic data for compounds 3 and 5 have been deposited at
the Cambridge Crystallographic Data Centre (CCDC) with deposition
numbers 1580057 (3) and 1580058 (5), respectively.†
2. Insulin and lysozyme fibril preparation
Human insulin (Sigma-Aldrich) was dissolved at 340 mM
(2 mg ml1) concentration in a 0.1 M water solution of HCl
(pH 2). Fibrils were formed by incubating the insulin solution
Table 1 Crystal and refinement data for compounds 3 and 5
Compound 3 5
Formula C17H21NO3 C48H54N2O6
Dcalc./g cm
3 1.203 1.243
m/mm1 0.662 0.647
Formula weight 287.35 754.93
Colour Clear yellow Clear yellow
Shape Prism Plate
Max size/mm 0.16 0.20
Mid size/mm 0.15 0.16
Min size/mm 0.08 0.08
T/K 123.00(10) 123.00(10)
Crystal system Orthorhombic Monoclinic
Flack parameter 0.1(2)
Hooft parameter 0.16(9)
Space group P212121 P21/n
a/Å 8.0221(2) 22.0779(2)
b/Å 8.5085(2) 7.22350(10)
c/Å 23.2424(4) 25.3699(3)
a/1 90 90
b/1 90 94.5190(10)
g/1 90 90
V/Å3 1586.43(6) 4033.41(8)
Z 4 4
Z0 1 1
Ymin/1 3.804 3.495
Ymax/1 73.410 73.556
Measured refl. 16 588 86 784
Independent refl. 3165 8076
Reflections used 2903 6959
Rint 0.0401 0.0409
Parameters 212 511
Restraints 0 0
Largest peak 0.151 0.230
Deepest hole 0.166 0.207
GooF 1.044 1.024
wR2 (all data) 0.0784 0.0961
wR2 0.0751 0.0908
R1 (all data) 0.0367 0.0416
R1 0.0316 0.0345
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in a thermo-mixer incubator at 65 1C for 5 h. Hen egg lysozyme
(Sigma-Aldrich) was dissolved at 1 mM (14.5 mg ml1) concen-
tration in a 0.1 M water solution of HCl (pH 2). Fibrillar
aggregates were formed by incubating the protein solution in
a thermo-mixer incubator at 65 1C for about 24 h. The 7519 dye
fluorescence assay was used to monitor amyloid aggregation.
The presence and the shape of aggregates were confirmed by
scanning electron microscopy.
3. Preparation of dye solutions
Stock solutions of dyes were obtained by dissolving the dyes
at 2 mM concentration in DMSO. Working solutions of free
dyes were prepared by diluting dye stock solutions in 50 mM
Tris–HCl buffer (pH 7.9) to a concentration of 2 mM. The working
solutions of the dyes in the presence of native or fibrillar
proteins were prepared by adding an aliquot of the dye stock
solution and an aliquot of the native or fibrillar protein solution
into 50 mM Tris–HCl buffer (pH 7.9).
4. Spectral measurements
Absorption spectra were recorded on a Cary 300 BIO UV-Vis
spectrophotometer at a dye concentration of 10 mM in DMSO
and in 50 mM Tris–HCl buffer (pH 7.9). Fluorescence excitation
and emission spectra were recorded on a Cary Eclipse fluores-
cence spectrophotometer (Varian); concentrations of the dye,
insulin and lysozyme were 2, 3.4 and 8 mM, respectively. The
wavelength of the fluorescence excitation was set to be equal to
the wavelength of the maximum of the fluorescence excitation
band of the dye in the corresponding solution. The excitation
and emission slit size was maintained at 5 nm during all
the measurements using a Cary Eclipse system. All spectral
measurements were performed in standard quartz cuvettes
(1  1 cm) at room temperature. The emission quantum yields
for dyes bound to insulin fibrils were determined directly using
a Hamamatsu photonic multichannel analyser C10027 equipped
with a Spectralons integrating sphere. Since the sphere cannot
measure precisely the values of quantum yield below 2%, we
have also determined the quantum yield values of the four free
dyes (2 mM) with the help of a Fluorolog C9920-02 system by a
relative method using Coumarin 307 solution in methanol as the
reference (quantum yield value 0.9229). All measurements were
performed at ambient temperature.
5. Time-resolved fluorescence
The time-resolved measurements of b-ketoenole dye fluores-
cence in complexes with fibrillar insulin and lysozyme were
made using a home-built setup, consisting of a PicoQuant
pulsed diode laser, a Digikro¨m CM112 monochromator working
in the subtractivemode, a Hamamatsu 3809MCP photomultiplier,
and a Becker&Hickl SPC-830 time-correlated single-photon-
counting module. Excitation was performed at 375 nm. The
concentrations used were 20, 8.5 and 20 mM for dye, insulin and
lysozyme, respectively, and 50 mM Tris–HCl buffer (pH 7.9) was
used as the solvent. Measurements were performed in fluores-
cence quartz cells (1  1 cm) at room temperature. The average
lifetime values (tAVE; intensity averaged) of the dye/amyloid
fibril complexes were calculated using the equation: t = t1 
B1 + t2  B2, where B1 and B2 are relative amplitudes deter-
mined by B1 = A1  t1/(A1  t1 + A2  t2) and B2 = A2  t2/
(A1  t1 + A2  t2); fluorescence lifetimes (t1, t2) and their
amplitudes (A1, A2) were obtained by fitting the fluorescence
intensity decays of the dye in the presence of fibrillar proteins
to the minimum number of exponential terms that produced
randomly distributed residuals.
The fluorescence intensity decay time (t) and the radiative
excited state lifetime (tr) of the free dye were calculated for four
selected dyes from the QY of the free dye (QYfree) and the dye in
the presence of the fibrils (QYbound) as well as tAVE (see above)
under an assumption that tr does not change noticeably in
the presence of fibrils according to t = tAVE  (QYfree/QYbound)
and tr = tAVE/QYbound.
6. Evaluation of aggregation kinetics
The reaction of insulin fibrillation was performed as described
above. Aliquots of the reaction mixture were withdrawn from
each tube at about 90, 150, 240 and 300 minutes after the
reaction was started and added to the 2 mM solution in 50 mM
Tris–HCl buffer (pH 7.9) of amyloid sensitive dye Thioflavin T
(used as the reference dye) and the investigated b-ketoenole dye 2.
Results and discussion
Syntheses and molecular structures
b-Ketoenoles presented here were obtained by a two-step procedure
(Scheme 1). In the first step, the corresponding (E)-4-hydroxy-6-
methyl-3-(3-arylacryloyl)-2H-pyran-2-one derivatives were obtained
by condensation of dehydroacetic acid with aromatic aldehydes, as
described in ref. 30 (Scheme 1, intermediate A). In the second step,
reaction of these intermediates with aliphatic amines resulted in
the opening of the pyran ring, decarboxylation and formation of
(2Z,5Z,7E)-6-hydroxy-2-(alkylamino)-8-arylocta-2,5,7-trien-4-one dyes
(Scheme 1, compound B). The mechanism of this reaction was
studied in detail in ref. 30 and 31. In this work, we proposed a
modification to our earlier used synthetic protocol.26 It was shown
that an increase of the reagent concentration, the temperature of
the reaction mixture and the shortening of the reaction time leads
to higher yields of the target products.
Compounds 3 and 5 crystallize as yellow plates in the
monoclinic crystal system (space group P21/n). Molecules of 3
and 5 display a planar arrangement of the polyene chain of
the ketoenol fragment conjugated with the aromatic ring at
position 8, phenyl and propoxyphenyl in 3 and 5, respectively
(Fig. 1). The planar configuration of the ketoenole group
is further stabilized by H-bonds between the 6-hydroxy and
4-keto functions. Similarly, H-bonding interactions between the
2-amino and 4-keto groups are present.
Fluorescence properties of dyes in the presence of native and
fibrillar proteins
To examine the fluorescence sensitivity of the novel dyes towards
protein fibrils, the fluorescence emission and excitation spectra
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were measured for the free dyes in buﬀer and after the addition
of native or fibrillar insulin and lysozyme. The main character-
istics of the fluorescence spectra are presented in Table 2,
and the spectra of dye 2 are shown in Fig. 2. The emission
spectra were recorded upon excitation at the maxima of the
excitation spectra.
Free dyes display very low fluorescence intensity with the
emissionmaxima in the range of 496–535 nm. Values of the shift
between the excitation and emission maxima are large (from
86 nm for 6 to 140 nm for 1), which is typical for b-ketoenoles
and is in agreement with previously reported results.26
Addition of native insulin (globular protein that mostly
contains alpha-helical motifs in its structure) causes minor
changes in the excitation and emission spectra. The emission
maxima shift unessentially to the long- or short-wavelength
region by up to 15 nm (Table 2). The emission intensity is
almost unaﬀected. For most compounds and Thioflavin T, the
fluorescence quantum yield of both free dyes (buﬀer solution)
and dyes in solutions containing native insulin is very small
(less than 2%). Only for compounds 1, 4, 5, and 6 did the
measured quantum yield exceed the threshold of our quantum
yield measurement setup, being ca. 2%, which amounted to
8.5%, 3.6%, 2.7%, and 3.7%, respectively (ESI,† Table S1).
The fluorescence characteristics of the studied b-ketoenoles
in the presence of fibrillar insulin (IF) are presented in Table 2.
The addition of b-ketoenoles to these protein aggregates resulted
in a strong increase of dye fluorescence intensity as compared to
that in buﬀer solutions (I0) and solutions containing native
protein (IN). The most prominent increase (the value of IF/I0
ratio equal to 295) is observed for dye 9, which bears a 2-hydroxy-
ethylamino tail group and a para-substituted phenyl moiety. The
essential enhancement of the fluorescence intensity in the
presence of fibrillar insulin also took place for dye 2 bearing a
2-methoxyethylamino tail group and a para-substituted phenyl
moiety, for the dyes 4 and 7 with alkylamino tail groups on one
end and 5-benzo[d][1,3]dioxole on the other end of the molecule,
as well as for dye 10. The values of IF/I0 ratio for dyes 2, 4, 7, and
10 are equal to 55, 66, 45 and 95 respectively, which is compar-
able with or higher than the corresponding value for Thioflavin T
(IF/I0 = 55). Besides, dye 2 also shows the highest value of
emission intensity in the presence of fibrillar insulin (Table 2).
For the dyes with para-substituted phenyl moieties (6 and 8), the
fluorescence intensity increase is less pronounced and is equal
to about 25 for both compounds, when referred to the respective
buﬀer solutions (Table 2).
It is remarked that the dye–fibril complexes of compounds 2
and 9 show very high fluorescence quantum yields of 0.47 and
0.38, respectively, which are higher than the quantum yields found
for any other b-ketoenole analogues so far.26 The quantum yield
values of the studied ketoenole dyes bound to fibrils were compar-
able with or higher (up to more than two times for dye 2) than
those of Thioflavin T (measured as 20%). The fluorescence quan-
tum yield of Thioflavin T incorporated into fibrils was reported to
be 43%.32 A small deviation of the QY by a factor of two as reported
in the cited work and as measured by us may be explained by
distinct inhomogeneity and the difference in the structure of the
fibril populations. It should be mentioned that the measured
quantum yield values might be slightly underestimated due to
absorption by the unbound dye form still present in solution.
Fig. 1 Perspective drawings of molecules 3 (top) and 5 (bottom) obtained
from X-ray diﬀraction studies. Thermal ellipses are shown at 50% probability.
Table 2 Fluorescence properties of b-ketoenole dyes in the presence of native and fibrillar insulin
Name
Buﬀer With native insulin With fibrillar insulin
lem (lex), nm I0, a.u. lem (lex), nm I
N, a.u. lem (lex), nm I
F, a.u. QY
1 521 (381) 7.2 521 (382) 8 507 (382) 10 0.04
2 535 (417) 3.1 533 (417) 3.2 540 (458) 172 0.47
3 503 (400) 0.7 498 (401) 0.9 500 (414) 18 0.28
4 507 (400) 0.9 492 (400) 1.7 495 (421) 59 0.20
5 512 (408) 29 510 (400) 23 500 (418) 80 0.28
6 496 (410) 2 496 (410) 4 497 (417) 50 0.24
7 505 (414) 0.8 514 (414) 0.9 500 (419) 36 0.26
8 529 (405) 3.1 524 (408) 3.4 552 (456) 76 0.30
9 508 (400) 0.2 499 (406) 0.2 495 (427) 59 0.38
10 512 (414) 0.2 514 (414) 0.2 514 (424) 19 0.18
Thioflavin T 526 (444) 2.2 520 (442) 2.5 483 (445) 120 0.20
lem – maximum of emission spectrum. lex – lowest energy maximum of excitation spectrum. I0, I
N, IF – emission intensity measured at lem
upon excitation at lex in buffer solution without protein, in the presence of native insulin, and in the presence of fibrillar insulin, respectively.
QY – fluorescence quantum yield.
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For each compound, the Stokes shifts determined from the
emission and excitation spectrum maxima are significantly
smaller in the presence of fibrillar insulin than for the free
dye buﬀer solution (68–125 nm vs. 86–140 nm respectively).
This difference along with the distinctly higher emission quan-
tum yields indicates the greater rigidity of the sites occupied by
dye molecules in the fibrillar protein as compared to the
solution and the closest environment of the dye in the presence
of non-fibrillar proteins. At the same time, these Stokes shifts
are still large enough from the point of view of the convenient
use of the dyes as fluorescent probes. It should be mentioned
that the Stokes shift value of Thioflavin T decreases from 82 to
38 nm upon the addition of insulin fibrils, which is much less
as compared to the studied dyes.
For dyes 2, 8, 9 and Thioflavin T that show a high increase of
emission intensity in the presence of fibrillar insulin, the
sensitivity towards fibrils formed by another amyloidogenic
protein lysozyme was studied. To evaluate the impact of the
substituent in the phenyl moiety on the amyloid-sensitive
properties of the dye, compound 3 that is a structural analogue
of highly eﬃcient dye 2, with a non-substituted phenyl group,
was also characterized with fibrillar lysozyme.
Based on a model of the ketoenoles binding to fibrils, the
placement of the dye molecule into the groove formed by the
beta-pleated sheets of the protein was assumed.26 At the same
time, amyloid fibrils formed by insulin and lysozyme have a
distinct morphology. Lysozyme consists of a single polypeptide
chain, which is involved in the fibril core formation, while
insulin chain A is suggested to be located at the outer surface of
the fibril and involved in lateral aggregation.33,34 Thus, com-
paring the sensitivity of the dyes to the fibrils with a diﬀerence
in the structure of beta-pleated motifs will allow estimating the
‘‘versatility’’ of b-ketoenoles as amyloid-sensitive probes.
The studied dyes have close positions of excitation and emis-
sion maxima and the same shape of spectra in the presence of
both fibrillar proteins. The fluorescence responses of b-ketoenole
dyes 2 and 8 to fibrillar insulin are higher as compared to those
of fibrillar lysozyme (Fig. 3) for the used concentrations, while
for the dyes 3 and 9, they are about equal. The most pronounced
fluorescence response in the presence of fibrillar lysozyme is
shown by the dye 9; though this dye also demonstrates the
highest response to native lysozyme.
b-Ketoenole dye molecules exhibit long fragments containing
conjugated double bonds that render a planar shape of the
molecules (Fig. 1). Thus, intercalating interactions with nucleic
acids can be expected. However, b-ketoenoles possess no response
to the presence of DNA (our data show that the emission intensity
of dye 2 in the presence of 60 mM b.p. of salmon tastes dsDNA
equals the emission intensity of free dye; separate work will
be published containing these data). This could be explained by
their low aﬃnity to nucleic acids due to the neutral charge of the
dye molecules, since nucleic acids strongly prefer binding with
positively charged molecules. This property does ‘‘increase the
selectivity’’ of ketoenole dyes to amyloid fibrils and is considered
as an advantage of these dyes for histological experiments.
Fig. 2 (A) Fluorescence emission spectra of dye 2 (1 mM) free and in the presence of native or fibrillar insulin (3.4 mM) in 50 mM Tris–HCl buffer (pH 7.9).
(B) Absorption spectra of dye 2 (5 mM) in 50 mM Tris–HCl buffer (pH 7.9) in the free state and in the presence of 17 mM native or fibrillar insulin, and
in DMSO.
Fig. 3 Diagram showing sensitivity of the dye luminescence to fibrillar
and native proteins, where IF/I0 – ratio of emission intensity of the dye in
the presence of fibrillar insulin (fINS) or lysozyme (fLYS) to that of the free
dye; IN/I0 – ratio of emission intensity of the dye in the presence of native
insulin or lysozyme to that of the free dye.
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Thus, we conclude that the new b-ketoenoles represent
potent amyloid fibril probes that exhibit a significant increase
of emission intensity amounting to dozens of times when
bound to fibrillar proteins and a negligible response to the
native proteins and nucleic acids. The emission spectra of these
dyes are characterized by large Stokes shifts required for
practical use as luminescent probes.
The sensing ability of the dyes towards amyloid fibrils is
strongly influenced by terminal groups, both the amino and
aromatic moieties. The response is significantly decreased by
long aliphatic chains and large aryl groups (dyes 1 and 5). This
is easily explained in the framework of the model of ketoenoles
binding with fibrils via noncovalent interactions with the grooves of
fibrillar proteins. In this case, the sterically demanding aliphatic
and/or aryl tails hinder the interaction due to the unsuitable shape
and size of the dye molecules.
Compounds exhibiting electron donating substituents (amino
group, ether group, methylendioxy group) at the terminal benzene
moiety conjugated with the backbone double bond system show
improved amyloid-sensing properties. For these dyes, in the
presence of fibrillar proteins, higher relative emission intensity
(IF) and higher emission increase as expressed by the IF/IN ratios
(Fig. 3) are observed. This eﬀect can be rationalized in terms of the
diﬀerent dispersive interactions between the dye and aromatic
groups of the protein. Electron-rich aromatic groups (i.e. benzenes
with electron donating substituents) tend to engage in stronger
p–p stacking interactions than electron-deficient moieties.
Absorption characteristics of the studied b-ketoenoles
Characteristics of the UV-Vis absorption spectra of free keto-
enoles in DMSO and aqueous buﬀer (50 mM Tris–HCl, pH 7.9)
are presented in Table 3; Fig. 4 shows the absorption spectra of
dyes 8 and 9 in these solvents. The spectra in aprotic DMSO
have broad bands and moderate extinction coefficients of the
main maximum in the range of (3.1–4.4)  104 M1 cm1. Their
maximum wavelengths are in the range of 400–440 nm; for
some of the dyes, the minor short-wavelength bands with
maxima at 322–334 nm are observed (data not presented). It
is suggested that the shape of the spectra and positions of the
maxima are influenced by the electron donor properties of
substituents in the aryl fragment.
Absorption spectra of the studied dyes in buﬀer (Table 3)
contain bands with the main maximum in one of the regions
(315–331 nm or 380–407 nm; and minor maximum in the other
one) or in both these regions, which might depend on the dye
conformation in buffer. The values of molar extinction coeffi-
cient of the main bands of the studied dyes in buffer are close
to those in DMSO. The highest value of extinction coefficient
(about 3.8  104 M1 cm1) is observed for dye 4.
Further, absorption spectra of the dyes with native and
fibrillar insulin were obtained. Upon addition of native insulin,
the form of the dye spectra does not change (see Fig. 2 for dye 2;
for other dyes, data not shown). In the presence of fibrillar
insulin, for dyes 2, 3, 4, 6, 7, 8, 9 and 10, an appearance or an
increase of the band at 406–430 nm is observed (Fig. 5; ESI,†
Table S2). The highly effective dye 2 upon addition of the
insulin fibrils shifts its absorption band maximum from 406
to 420 nm and increases the band intensity (Fig. 2B). Such
changes could be explained by a dye conformation transition
from non-fluorescent unbound form to fluorescent (bound to
amyloid fibrils) form. However, such a growth of the long-
wavelength band is not observed for dye 8, which already has
two absorption bands in the free state (314 and 409 nm).
Furthermore, the long-wavelength absorption bands
(406–430 nm) are close to the fluorescence excitation bands
(417–458 nm) for dyes bound to insulin fibrils. Thus, it could be
supposed that the dye–fibril fluorescent complex absorbs in
this region (406–430 nm).
Fluorescence decay time of dye–fibril complexes
To characterize the complexes formed by the dyes with fibrils,
we measured fluorescence decays for b-ketoenoles 2, 8, 9 (dyes
giving strong fluorescence response) and 3 in the presence of
insulin and lysozyme fibrils. The decays are not monoexponential
Table 3 Characteristics of UV-Vis absorption spectra of the dyes
Name
Buﬀer solution (Tris–HCl pH 7.9) DMSO
lmax, nm e, 10
4 M1 cm1 lmax, nm e, 10
4 M1 cm1
1 380 0.8 406 3.7
2 318 1.3 438 3.5
405 1.6
3 316* 2.7 401 3.7
400 0.25
4 318 3.8 407 3.8
5 401 2.8 418 4.4
6 318* 2.7 401 3.8
401 0.28
7 316 2.4 407 5.1
8 314* 1.7 439 4.3
409 2.2
9 329 2.3 404 3.3
10 328 2.2 411 3.1
lmax – maxima of UV-Vis absorption spectra, nm; e – molar extinction
coefficient, M1 cm1; * – shoulder of the main band.
Fig. 4 Normalized absorption spectra of dye 8 in DMSO and 50 mM
Tris–HCl buffer and 9 in 50 mM Tris–HCl buffer and DMSO.
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and could be adequately fitted with biexponential decay func-
tions with decay times t1 (short) and t2 (long), respectively. The
numerical data are listed in the Table 4.
In the presence of fibrillar insulin, the values of t1 are close
for dyes 2 and 8 both containing 4-N,N-dimethylaminophenyl
substituents (0.18 and 0.19 ns, respectively); this diﬀers them
from the two other dyes with phenyl (3) and 4-propoxyphenyl (9)
substituents (t1 values are 0.48 and 0.43 ns, respectively). At the
same time, the values of the long decay time (t2) are close for all
for dyes (1.40–1.47 ns). The relative intensity B1 of the compo-
nent with the short decay time is smaller than the relative
intensity B2 of the long decay component in the case of all
investigated dyes except 9. The value of the average decay time
(tAVE) is near for all four studied dyes (between 0.9 and 1.1 ns).
As for the dyes in the presence of fibrillar lysozyme,
generally, the same tendencies are observed. The values of
the short component t1 for dyes 2 and 8 (0.11 and 0.08 ns,
respectively) are lower as compared to the t1 values for dyes 3
and 9 (0.30 and 0.24 ns, respectively), while the values of the
long component t2 are close for all four dyes in the presence
of lysozyme fibrils (1.31–1.54 ns). The relative intensity B1
of the short component is smaller than B2 for all four investi-
gated dyes. The values of tAVE are between 1.1 and 1.3 ns. The
somewhat higher values of average decay time in the case of
fibrillar lysozyme as compared to insulin are due to the lower
contribution of the short decay component in the former case.
The obtained values of tAVE could be compared with that for
Thioflavin T in complex with Ab(1–42) fibrils (up to 0.63 ns).35
The two-component origin of the fluorescence decay could
possibly correspond to two tautomeric forms of the dyes. For
related compounds, the existence of a set of tautomeric forms
of the ketoenol fragment was established by NMR.36 Another
possible explanation could be the formation of two kinds of
dye–fibril complexes with, e.g., different degrees of rigidity of
the dye molecule fixated on the fibril. In any case, since all the
studied dyes have similar components of the fluorescence
decay in the case of both fibrillar proteins, we could suppose
that the origin of these components is the same for all dyes.
Since the values of quantum yield for the free dyes 2, 3, 8 and 9
cannot be precisely measured by the sphere, these values were
determined by a relative method (see ‘‘Materials and Methods’’
section). For the free dyes 2 and 8, the values of QY are about 0.5%,
while for dyes 3 and 9, these values are noticeably lower and equal
to 0.15% and 0.04%, respectively (Table 5). Based on the values of
tAVE as well as fluorescence quantum yield of the free dyes and
dyes in the presence of fibrillar insulin, the average values of
excited state lifetime of free dyes were calculated (Table 5) to be of
the order of 1.6–18 picoseconds. The lifetime values for the free
dyes 2 and 8 (11 and 18 ps, respectively) are much higher as
compared to dyes 3 and 9 (1.6 and 3.5 ps, respectively).
In summary, it could be concluded that the presence of
fibrillar proteins results in a strong increase in both the fluores-
cence quantum yield and fluorescence intensity decay time of
the studied b-ketoenole dyes.
Monitoring of fibril formation kinetics
The emission changes due to binding with beta-pleated motifs
permit us to quantify fibril formation. Thus, compound 2 was used
for monitoring the kinetics of amyloid aggregation of proteins.
To estimate the applicability of dye 2 (most eﬃcient as
reporter among studied b-ketoenoles) to monitor the kinetics
of insulin fibrillation, this dye was applied as a reporter
during the aggregation in comparison with Thioflavin T as a
Fig. 5 Absorption spectra of the dyes 6 (A) and 9 (B) in 50 mM Tris–HCl buffer in free state and in the presence of fibrillar insulin.
Table 4 Characteristics (decay times t1, t2 and relative intensities B1, B2)
of fluorescence intensity decay curves for selected dyes in the presence of
fibrillar insulin (fINS) and fibrillar lysozyme (fLYS), and the values of average
decay time (tAVE)
Sample T1, ns B1 t2, ns B2 tAVE, ns wred
Dye 2 20 mM + fINS 8.5 mM 0.18 0.30 1.40 0.70 1.0 8.42
Dye 3 20 mM + fINS 8.5 mM 0.48 0.36 1.47 0.64 1.1 4.72
Dye 8 20 mM + fINS 8.5 mM 0.19 0.29 1.46 0.71 1.1 6.35
Dye 9 20 mM + fINS 8.5 mM 0.43 0.55 1.42 0.45 0.9 3.76
Sample T1, ns B1 t2, ns B2 tAVE, ns wred
Dye 2 20 mM + fLYS 20 mM 0.11 0.22 1.46 0.78 1.2 2.09
Dye 3 20 mM + fLYS 20 mM 0.30 0.26 1.46 0.74 1.15 1.43
Dye 8 20 mM + fLYS 20 mM 0.08 0.19 1.54 0.81 1.3 2.15
Dye 9 20 mM + fLYS 20 mM 0.24 0.19 1.31 0.81 1.1 2.06
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reference dye.37 Two main stages of the aggregation reaction,
i.e. lag-phase (nucleation) and fibril growth,38 are characteristic
of amyloid fibril formation. As shown on the kinetics curves
(Fig. 6A), both dyes reflect those two stages. The kinetic curve of
insulin fibrillation obtained with dye 2 is of a similar shape to
that for Thioflavin T but it has a higher intensity of fluores-
cence signal. Since dye 2 reflects the passing of protein fibrilla-
tion with good eﬃciency, it could be proposed as a tool for
monitoring protein aggregation and using in amyloid–fibril
inhibitory assay.
Detection range for dye 2
To examine the sensitivity of dye 2 to quantify amyloid forma-
tions, we have studied the concentration range of the fibrillar
insulin detection using this dye. For this, the titration of 2 mM
dye solution with increasing amounts of fibrils was performed.
The lower detection limit was determined as two times the
increase of fluorescence intensity upon binding to fibrils and
the upper limit was estimated as the concentration where
fluorescence intensity approached saturation. The fluorescence
intensity of dye 2 upon increasing the insulin concentration
increases monotonically in the range of 0.8–100 mg ml1
(Fig. 6B), which is higher than that for the amyloid-specific
dye Thioflavin T (0.5–40 mg ml1).
Conclusions
A series of new functionalized (2Z,5Z,7E)-6-hydroxy-2-(alkylamino)-
8-arylocta-2,5,7-trien-4-one compounds was synthesized and
studied as probes for fluorescence detection of amyloid aggre-
gates of proteins. The chemical advantages of these dyes are
that they are not expensive and the availability of parent
compounds together with the cost-eﬀective, rather easy, two-
step protocol of their synthesis that does not require the
procedure of chromatographic separation.
Depending on the nature of the substituents, these dyes
could increase their emission intensity up to dozens of times
upon the presence of fibrillar aggregates, while being slightly
sensitive to native proteins. Both amino tail substituents and the
aryl moiety in the dye molecule determine its amyloid-sensing
properties. The electron donating substituents in the benzene
moiety (amino group, ether group, methylendioxy group) lead to
the increase of the amyloid-sensing properties of the dye.
The studied dyes possess green-yellow emission (495–540 nm)
and large (68–125 nm) Stokes shift values. For the most effective
compound 2 that bears a 2-methoxyethylamino tail group and
para-substituted phenyl moiety, the fluorescence quantum
yield upon binding to insulin fibrils reaches 47% while for
the free dye, this value is about 0.5%.
The quantum yield value of dye 2 complexed with fibrils is
shown as twice that of the commonly used dye Thioflavin T;
besides, dye 2 possesses a Stokes shift of about 80 nm while for
Thioflavin T, this value is about 40 nm. Those factors are
suggested as advantages of this ketoenole dye. A wide concen-
tration range of insulin fibril detection (0.8–100 mg ml1) and the
applicability for real-time monitoring of the kinetics of fibril
formation were shown for this dye.
Table 5 Photophysical characteristics of selected dyes free and in the
presence of fibrillar insulin
Dye
Dye Dye + fibrillar insulin
tr, ns (calculated)QY T, ns (calculated) QY tAVE, ns
2 0.0052 0.011 0.47 1.0 2.2
3 0.0004 0.0016 0.28 1.1 3.9
8 0.0049 0.018 0.30 1.1 3.7
9 0.0015 0.0035 0.38 0.9 2.3
QY – fluorescence quantum yield (measured directly for the dyes in the
presence of insulin fibrils and by a relative method for the free dyes; see
‘‘Materials and Methods’’ section); tAVE – average decay time of the dye
in the presence of insulin fibrils (from Table 4); t and tr – fluorescence
intensity decay time and radiative excited state lifetime of the free dye
calculated from QY of the free dye and dye in the presence of the fibrils
as well as tAVE under an assumption that tr does not change noticeably
in the presence of fibril.
Fig. 6 Kinetics of human insulin fibrillation assessed with fluorescence emission of Thioflavin T and dye 2 using a 2 mM dye concentration (A). Titration of
dye 2 (2 mM) with fibrillar insulin (concentration range 0.8–100 mg ml1) (B).
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The average values of fluorescence intensity decay time for
dyes upon binding to protein fibrils are strongly enhanced and
are in the range of 0.9–1.3 ns. The two-component origin of
the fluorescence decay is suggested to correspond to two
tautomeric forms of the dye or two different mechanisms of
dye–fibril binding.
Due to their attractive features, b-ketoenole dyes are con-
sidered as prospective fluorescent tools for amyloid fibril
detection, the study of protein aggregation and forming a basis
for fluorescence amyloid-inhibitory assay. Besides, they are
suggested for further study as stains for visualization methods,
particularly fluorescence microscopy.
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